Ikarian Capital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-155,599
| Closed | -$1.44M | – | 240 |
|
|
2021
Q1 | $1.44M | Buy |
155,599
+98,456
| +172% | +$911K | 0.05% | 118 |
|
|
2020
Q4 | $398K | Buy |
+57,143
| New | +$398K | 0.02% | 109 |
|
|
2020
Q3 | – | Sell |
-3,184
| Closed | -$29K | – | 156 |
|
|
2020
Q2 | $29K | Hold |
3,184
| – | – | ﹤0.01% | 86 |
|
|
2020
Q1 | $46K | Hold |
3,184
| – | – | ﹤0.01% | 73 |
|
|
2019
Q4 | $38K | Buy |
+3,184
| New | +$38K | 0.01% | 50 |
|